World

Trump administration scraps Biden policy on emergency abortions

Jun 04, 2025

Washington [US], June 4: U.S. President Donald Trump's administration on Tuesday rescinded guidance issued during his Democratic predecessor Joe Biden's tenure requiring hospitals to provide abortions to women in medical emergencies regardless of various state bans on the procedure.
The U.S. Centers for Medicare & Medicaid Services said the 2022 guidance, which interpreted a federal law that ensures patients can receive emergency "stabilizing care" as preempting state abortion bans, did not reflect the policy of the Trump administration.
The agency, which is part of the U.S. Department of Health and Human Services, said it "will work to rectify any perceived legal confusion and instability created by the former administration's actions."
The Biden administration issued the guidance in July 2022, weeks after the 6-3 conservative majority U.S. Supreme Court overturned its 1973 Roe v. Wade ruling that had recognized a nationwide right of women to obtain abortions.
The 2022 guidance reminded healthcare providers across the country of their obligations under a 1986 federal law called the Emergency Medical Treatment and Labor Act (EMTALA) to ensure Medicare-participating hospitals offer emergency care to stabilize patients regardless of their ability to pay.
Medicare is the government healthcare program for the elderly. Hospitals that violate EMTALA risk losing Medicare funding.
The 2022 guidance aimed to make clear that under EMTALA, physicians must provide a woman an abortion if needed to resolve a medical emergency and stabilize the patient, even in states where the procedure is banned, and that the federal law preempted any state laws that offer no exceptions for medical emergencies.
After issuing the guidance, the U.S. Department of Justice sued the state of Idaho in a bid to stop it from enforcing its near-total abortion ban in medical emergencies.
A federal judge at the Justice Department's urging blocked Idaho from enforcing the ban during medical emergencies, but the Trump administration in March dropped that lawsuit, resulting in that injunction being lifted.
The ban still remains blocked in emergencies due to a similar lawsuit brought by a hospital system.
Source: Fijian Broadcasting Corporation

More news

Infosys: Differentiated AI strategy and a sharp focus on value unlock propels 29% sequential growth in AI revenues

Bengaluru (Karnataka) [India], October 23: Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in AI-first business consulting and technology services, delivered $5,145 million in Q2 revenues, year on year growth of 1.5% and sequential growth of 1.2% in constant currency. Operating margin was stable at 21.0%. EPS growth was 8.7% year on year in rupee terms. TCV of large deal wins was $5.2 billion, with 62% net new. Robust Q2 large deal TCV at $5.2 billion with 62% net new; lays solid foundation for future growth. FY 27 revenue guidance revised to 1%-2% and margin guidance retained at 20%-22%.

Oct 23, 2026